Corporate & Background
 Custom Manufacturing
 Business & Products
 Facilities & Strengths
 Ethics & Values
 Regulatory Submissions
 Investors & Financials
 Sustainability
 Careers
 Locations & Contact
 Media Center
 Enquiry
     Our Nutraceuticals website
      News & Events
  Divi's Labs earns an Income of Rs.417 crores in Q3 of FY12
  Divi's Labs earns an Income of Rs.366 crores in Q2 of FY12
 Divi's Labs earns a PBT of Rs. 130 crores for Q1 of FY12
 Divi's Labs PAT for Q4 grew by 36% to Rs.175 crores
 Divi's Labs earns an Income of Rs.313 crores for Q3 of FY11
 Divi's Labs earns an Income of Rs.265 crores in Q1
 Divi's Labs earns a PAT of Rs.129 crores for Q4
 Divi's Labs earns an Income of Rs.649 crores for 9M of FY10
 Divi's Labs earns an Income of Rs.445 crores in H1 of FY10
 Divi's Labs earns a PAT of Rs.417 for the year 2008-09 And declares 1:1 bonus
 Divi's Labs PAT for 9 months
grows by 21% to Rs.309 crores
 Divi's Labs PAT for Q2 grows by
49% to Rs.135 crores
 Divi's Labs PAT for Q1 grows by
45% to Rs.94 crores
 Divi's Labs PAT for FY08 grows by 87% to Rs.348 crores
 Divi's Labs PAT for Q3 grows by 216% to Rs.99 crores
 Divi's Labs PAT for Q2 grows by 204% to Rs.91 crores
 Divi's Labs PAT for Q1 grows by 153% to Rs.65 crores
 Divi's Labs PAT for FY07
grows by 167% to Rs.186 crores
 Divi's Labs Q3 total income
 grows by 38% to Rs.152 crores
 Divis successful US-FDA inspection for Unit II
 Divi's Labs Q2 total income
 grows by 97% to Rs.165 crores.
 Divi's Labs Q1 total
 income grows by 142% at
 Rs.165 crores
 Divi's Laboratories earns a
 Net of Rs.19 crores
 on an Income of
 Rs.110 Crores in Q3
 Divis labs SEZs cleared
 Divis Laboratories earns a
 PBT of Rs.43 Crores in
 First-Half of FY06
 Divis Laboratories earns a
 total income of Rs.68
 Crores in Q1 of FY06
 Divis Laboratories earns a
 total income of Rs.365
 Crores in FY05
 Divis Laboratories earns a
 Net of Rs.105 Crores in Q3
 Divis Laboratories earns a
 PBT of Rs.45 Crores in
 First-Half of FY05
 Divis Laboratories earns a
 Net of Rs.14 Crores in Q1
 
CNBC TV18 INDIA BUSINESS LEADER AWARD 'FIRST GENERATION ENTREPRENUER OF THE YEAR'
Dr. Murali K Divi has been honoured with First Generation Entrepreneur of the Year Award by CNBC TV18......CNBC TV18
Chairman Speech - 2011
Good Morning. I extend a hearty welcome to you all, to this 20th Annual General Meeting of the Company.....Products
Corporate Governance Report 2009-10
Company Profile
Established in the year 1990, with Research & Development as its prime fundamental, Divis Laboratories focussed on developing new processes ....Company Profile
Products Products
Generic APIs, Intermediates, Peptide Building Blocks, Carotenoids, Future Generics ....Products
R & D
The main aim of the Divis R&D Centers is to design, develop and optimize commercially viable synthetic processes for APIs and Intermediates of Generics .... R & D
 

Copyright © 2006, Divis Laboratories Ltd. All Rights Reserved         Web design by Sumudra